• invalid-0

    We have developed a new female condom concept intended to be more attractive and pleasurable for both partners. The “ORIGAMI FC” has a ‘no-fumble’ method of insertion that is quick and easy to use. We anticipate R&D funding in Nov 2009 and plan to commercialize it by 2016.

    As with the Reality brand FC1 and FC2, the R&D is quite lengthy and it will cost several million dollars. In the meantime, we wholeheartedly support the expanded global promotion, distribution and use of the new FC-2.

    We believe that the ORIGAMI FEMALE CONDOM will eventually set a new global standard and become the preferred condom for BOTH men and women, which could surpass male condoms 3 to 1 by 2022.

    Researchers interested in using the ORIGAMI FC for US or international FC studies are encouraged to contact Dan Resnic; Email: resnicpi@gmail.com – TEL: 1-310-305-2984 in Los Angeles, CA , USA – or by Skype: danindesert .

  • invalid-0

    Hola Serra,
    compartimos que el derecho a una sexualidad placentera debe estar lejos de correr riezgos de vida para las mujeres. Es interezante el trabajo y el informe sobre Uganda donde podemos encontra similitudes con las situacion de las mujeres en America latina. Sigue siendo una cuestion de voluntad politica cuidar la vida de las mujeres.
    cariños, Coca Trillini.

  • invalid-0

    Cupid Ltd. has developed a unique latex based female condom which is user friendly and less expensive than the currently available female condoms. People interested to learn more about this new product, marketed by Cupid, should contact Om Garg at Email- Omramtrading@att.net
    phone number (440) 331-7946

  • invalid-0


    Those involved in the Ugandan re-launch of the female condom may be interested in two research articles I wrote documenting issues which arose during the distribution and promotion of the first female condom in Africa in the late 1990s-2000s. These articles are “It’s some kind of women’s empowerment: The ambiguity of the female condom as a marker of women’s empowerment” (Social Science and Medicine 52, 2001) and “The future of female-controlled barrier methods for HIV prevention: female condoms and lessons learned” (Culture, Health and Sexuality 6:6, 2004). The latter contains some material from Uganda. If anyone is interested in these articles but unable to access them, please let me know by email and I’ll be glad to send you a PDF. I am very interested in the possibilities of female barrier methods to provide women with greater control over their sexual and reproductive risks, so I’m happy to hear that the FC2 is being re-launched in Uganda. Best wishes for success, Amy Kaler

  • invalid-0

    We are interested to have a copy of your 2004 article about FC1 use in Uganda.

    Also we are keen to participate in the distribution of Cupid’s Latex based female condoms at competitive price.Please let us know how we can participate?

    Thank You
    OM GARG Cupid Ltd. Manufacturer of Female Condoms
    Cleveland Ohio

  • invalid-0

    The training was indeed an important event for the advocacy for the female condom in the country and well timed considering that MoH is finalizing the situational analysis and operational plan. The female condom does need intensified, concurrent and positive promotion from different key stakeholders (government, civil society and development partners) to influence policy and prioritization at planning and budgeting levels, but mostly to promote acceptability among females and males for increased uptake and reduce stigma and biases. There is need to demonstrate demand for this technological method to influence programming. And civil society organizations (CSOs) are best suited to establish this demand and lobby through different planning fora in the health and HIV/AIDS worlds for priority focus on the FC.

    As we intensify this advocacy, the following issues that came from the discussions during the training need to be addressed:
    • CSOs need to be fairly familiar with the government systems (and politics) especially for planning and budgeting processes to achieve results from advocacy efforts. Workshop participants for example had the perception that donors can directly influence government to prioritize issues – an impression that was fortunately corrected during consultations with donors and Ministry of Health. CSOs need to participate in evidence generation efforts including documenting demand and take lead in advocating for some aspects as national partners to provide the basis on which donors can also take on issues
    • Similarly, CSOs need to proactively identify entry points but also be supported to ensure their participation in key policy and planning fora. Often the nature of CSO representatives in different fora do not represent actual issues as obtaining in the constituencies – due to poor consultations and sometimes lack of interest in specific issues
    • Advocacy for the Female condom needs to take into perspective the dual protection aspects to avoid skewed communication and public understanding. Whereas the currently parallel RH and HIV worlds can potentially intensify advocacy for FC for better results, poor coordination between the two to ensure message consistency might lead to biased perspectives about FC with limited desired outcomes at individual and programming levels. There should not be a repeat of the male condom situation that has largely been promoted from the HIV perspectives. As such the Ministry of Health and the Uganda AIDS Commission need to be targeted concurrently to utilize both planning process until RH/HIV integration concepts take root in the country.
    • Similarly, all care must be taken to ensure that the FC is not promoted as a magic bullet. In a country where Ministry of Health reported (in 2005) 92% of couples are HIV negative concordant, featuring HIV in the remaining 8% of couples (HIV+ concordant or discordant), it might be unrealistic to expect that FC will take the place of other prevention measures such as couple testing and being faithful. As such, our FC advocacy needs to be well positioned in the nationally agreed HIV Comprehensive Prevention Package, ensuring tailored prevention interventions to specific environments around individuals.
    • As we promote the FC, we also need to learn from experiences from promoting the male condom in Uganda. While widely accepted in Uganda and relatively accessible, male condom use in long term sexual relationships is as low as 5%, yet this is where most new HIV infections are occurring. Consistent condom use is challenge even with the documented concurrent multiple sexual relationships. Most social, cultural, religious and economic factors that influence male condom use will also impact on FC use and need to be anticipated. Indeed FC promotion should not be delinked from male condom promotion but be used to provide opportunities for couple choices
    • To an extent the FC is a male condom! The gender inequality issues and lack of negotiation skills for condom use on the side of females are still with us. The FC alone will not provide the needed empowerment to the female partner. Advocacy for comprehensive programming to focus on gender roles, norms and expectations in different settings is still key.
    The training ended on a very positive note – the formation of an FC advocacy coalition that should ignite action in the civil society world. We however need to ensure that the fears raised by participants on what can easily kill this innovation (e.g. turning it into an organization, poor mobilization of other CSOs that did not participate, lack of transparency, and advocacy/activism that is not evidence based) are systematically addressed. UNFPA pledged to provide technical support and meeting room where necessary in the formative stages

Mobile Theme